Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2/3 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1Genitourinary 1Endocrine 1

Conditions

Colonic Neoplasms 2Stomach Neoplasms 1Neoplastic Cells, Circulating 1Lymphatic Metastasis 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Conversion to Open Surgery × Gastrointestinal × 1 year × Clear all
NCT07314996 2026-06-03

LOVO

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
664 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03776591 2026-05-14

D3/CME

Haraldsplass Deaconess Hospital

Phase NA Active not recruiting
128 enrolled
Gastrointestinal

Colonic Neoplasms, Lymphatic Metastasis, Neoplastic Cells, Circulating

NCT07241715 2026-05-14

CONVERGENCE

National University Hospital, Singapore

Phase 2/3 Active not recruiting
300 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡